These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28776100)

  • 1. Dalbavancin for outpatient parenteral antimicrobial therapy of skin and soft tissue infections in a returning traveller : Proposal for novel treatment indications.
    Mischlinger J; Lagler H; Harrison N; Ramharter M
    Wien Klin Wochenschr; 2017 Sep; 129(17-18):642-645. PubMed ID: 28776100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
    Chan M; Ooi CK; Wong J; Zhong L; Lye D
    BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups.
    Changchien CH; Chen SW; Chen YY; Chu C
    BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome.
    Ruhe JJ; Smith N; Bradsher RW; Menon A
    Clin Infect Dis; 2007 Mar; 44(6):777-84. PubMed ID: 17304447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.
    Meddles-Torres C; Hu S; Jurgens C
    J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria.
    Stevens DL
    J Infect; 2009 Sep; 59 Suppl 1():S32-9. PubMed ID: 19766887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus.
    Ray GT; Suaya JA; Baxter R
    Diagn Microbiol Infect Dis; 2013 May; 76(1):24-30. PubMed ID: 23537783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: oral antimicrobial agents.
    Zervos M
    Surg Infect (Larchmt); 2008; 9 Suppl 1():s29-34. PubMed ID: 18844472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dalbavancin in the treatment of different gram-positive infections: a real-life experience.
    Bouza E; Valerio M; Soriano A; Morata L; Carus EG; Rodríguez-González C; Hidalgo-Tenorio MC; Plata A; Muñoz P; Vena A;
    Int J Antimicrob Agents; 2018 Apr; 51(4):571-577. PubMed ID: 29180276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Lawrence KR; Golik MV; Davidson L
    Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antimicrobial therapy for treatment of uncomplicated skin and soft tissue infections from community-acquired methicillin-resistant Staphylococcus aureus in children.
    Teng CS; Lo WT; Wang SR; Tseng MH; Chu ML; Wang CC
    J Microbiol Immunol Infect; 2009 Aug; 42(4):324-8. PubMed ID: 19949756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe.
    Nurjadi D; Friedrich-Jänicke B; Schäfer J; Van Genderen PJ; Goorhuis A; Perignon A; Neumayr A; Mueller A; Kantele A; Schunk M; Gascon J; Stich A; Hatz C; Caumes E; Grobusch MP; Fleck R; Mockenhaupt FP; Zanger P
    Clin Microbiol Infect; 2015 Jun; 21(6):567.e1-10. PubMed ID: 25753191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management and outcome of adults with skin and soft tissue infection caused by methicillin-resistant Staphylococcus aureus in a tertiary hospital in central Taiwan.
    Teh SH; Chi CY; Lin PC; Ho CM; Chou CH; Tsai CT; Wang JH; Ho MW
    J Microbiol Immunol Infect; 2015 Oct; 48(5):497-503. PubMed ID: 25446039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical importance of purulence in methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Crawford SE; David MZ; Glikman D; King KJ; Boyle-Vavra S; Daum RS
    J Am Board Fam Med; 2009; 22(6):647-54. PubMed ID: 19897693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus among skin and soft tissue infections in an emergency department in Guyana.
    Dozois A; Thomsen I; Jimenez-Truque N; Soper N; Pearson A; Mohamed-Rambaran P; Dettorre KB; Creech CB; Wright SW
    Emerg Med J; 2015 Oct; 32(10):800-3. PubMed ID: 25552545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Bassetti M; Baguneid M; Bouza E; Dryden M; Nathwani D; Wilcox M
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():3-18. PubMed ID: 24580738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center.
    Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z
    Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections.
    Rhoads JLW; Willson TM; Sutton JD; Spivak ES; Samore MH; Stevens VW
    Clin Infect Dis; 2021 Feb; 72(4):675-681. PubMed ID: 32047886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. French national cohort of first use of dalbavancin: A high proportion of off-label use.
    Dinh A; Duran C; Pavese P; Khatchatourian L; Monnin B; Bleibtreu A; Denis E; Etienne C; Rouanes N; Mahieu R; Bouchand F; Davido B; Lotte R; Cabaret P; Camou F; Chavanet P; Assi A; Limonta S; Lechiche C; Riou R; Courjon J; Illes G; Lacassin-Beller F; Senneville E;
    Int J Antimicrob Agents; 2019 Nov; 54(5):668-672. PubMed ID: 31400471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.